Pharmacology Pegvaliase was approved by FDA in 2018 for A Phenylketonuria B Pancreatic tumours C Crohn's disease D Glycogen storage disorders 💡 Explanation Pegvaliase was approved by FDA in 2018 for ✓ Correct Answer: A. Phenylketonuria